• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
PAN Mengqi,HU Weiwei.Research progress on the regulatory roles of retinoblastoma protein-binding protein family members in tumorigenesis and development[J].Journal Of Pharmaceutical Research,2025,44(10):989-996,1019[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 1621times   Download 680次 QR Code for this article
Scan with your phone!
视网膜母细胞瘤蛋白结合蛋白家族成员调控肿瘤发生发展研究进展
潘梦绮,胡唯伟
Font:Larger+|Default|Smaller-
(中国药科大学药学院,江苏 南京 210009)
摘要:
pRb的结合蛋白RBBP家族作为连接pRb与表观遗传调控的核心枢纽分子,其关键成员在细胞周期控制、染色质重塑及基因转录调控中发挥核心作用。RBBP家族成员在肿瘤发生、干细胞维持、转移及耐药中呈现双重作用,针对其结构域的小分子抑制剂开发及表观遗传调控网络的干预策略已展现出显著抗肿瘤潜力。本文系统综述RBBP家族调控肿瘤发生发展的研究进展,旨在为开发基于表观遗传调控的精准治疗策略提供思路。
关键词:  视网膜母细胞瘤结合蛋白  肿瘤  表观遗传调控
DOI:10.13506/j.cnki.jpr.2025.10.009
基金项目:国家自然科学基金项目(No.82373911)
Publication Date:October 25, 2025
Research progress on the regulatory roles of retinoblastoma protein-binding protein family members in tumorigenesis and development
PAN Mengqi,HU Weiwei
(School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China)
Abstract:
The retinoblastoma protein (pRb)-associated RBBP family, serving as core hubs linking pRb pathway with epigenetic regulatory networks, plays pivotal roles in cell cycle control through mediating chromatin remodeling complex assembly and gene transcription regulation. Emerging evidence reveals context-dependent dual functions of RBBP members in tumorigenesis: while promoting cancer stemness maintenance and metastasis via epigenetic silencing in most malignancies, they exhibit tumor-suppressive activities in specific tissue microenvironments. Structure-based inhibitor development targeting RBBP functional domains, coupled with combinatorial strategies against epigenetic regulatory circuits, has demonstrated significant anti-tumor therapeutic potential. This review systematically summarizes recent advances in understanding RBBP family's regulatory roles in tumor initiation and progression, aiming to explore novel paradigms for precision oncology targeting epigenetic dysregulation.
Key words:  Retinoblastoma-binding protein  Tumor  Epigenetic dysregulation
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.